# Dash Bio

> Dash Bio is a Boston-based bioanalytical contract research organization serving biotech and pharmaceutical developers. Its automated lab combines robotics, proprietary software and scientific expertise to develop, validate and run assays under fixed, published pricing.

- **Founded:** 2024
- **Headquarters:** Boston, United States
- **Founders:** Dave Johnson (Co-founder and CEO), Ander Tallett (Co-founder and COO), Ely Porter (Co-founder and CSO)
- **Products:** Method development and transfer, Method validation, ELISA and MSD, LC-MS, qPCR and ddPCR
- **Notable:** USD 47.5 million total disclosed funding by August 2026., Over 30 contracted customers reported in August 2026., Five assay platforms reported online by December 2025.

## Products & services

- **Method development and transfer** — Custom assays and transfer of established methods onto automated workflows. Sponsors own paid-for assay IP.
- **Method validation** — GLP/GCP validation, protocol control and documented audit trails.
- **ELISA and MSD** — Ligand-binding analysis for drug exposure, response, immunogenicity and biomarkers.
- **LC-MS** — Mass-spectrometry bioanalysis with automated sample preparation.
- **qPCR and ddPCR** — Nucleic-acid assays with extraction and automated handling.
- **Self-service quoting** — Online study cost estimates using published prices.
- **Sample preparation** — Tissue homogenization, nucleic-acid extraction and custom preparation workflows.

## Achievements

- USD 47.5 million total disclosed funding by August 2026.
- Over 30 contracted customers reported in August 2026.
- Five assay platforms reported online by December 2025.
- Company reports a 24,000-square-foot GLP laboratory in Waltham.

## Latest updates

- **2026-08** — USD 30 million Series A announced; plans include commercial expansion, assay menu and capacity growth, and proprietary software development.
- **2026-03** — Johnson published a two-part analysis of queues and billable-hour incentives in CRO operations.
- **2025-12** — Dash announced a planned move from its pilot lab to a 24,000-square-foot Waltham facility and introduced self-service quoting.

## Links

- Website: https://www.dash.bio/
- LinkedIn: https://www.linkedin.com/company/dashbio/

---

Profile page: https://yespress.io/dash-bio
Published by YesPress — https://yespress.io
Last updated: 2026-10-03